Access Afp Immunoassay System

FDA premarket approval P980041 · Kit, Test, Alpha-Fetoprotein for Neural Tube Defects

PMA numberP980041

Approval

Applicant
Beckman Coulter, Inc.
Received
October 16, 1998
Decision date
February 8, 1999 (APPR)
Supplements
47, latest November 3, 2025
Product code
LOK – Kit, Test, Alpha-Fetoprotein For Neural Tube Defects

Official FDA PMA record

Approval order statement

Approval for the Access(R) AFP Reagents on the Access(R) Immunoassay Analyzer. The Access(R) AFP assay is a paramagnetic particle, chemiluminescent immunoassay for use with the Access(R) Immunoassay System for the quantitative determination fo alpha-fetoprotein (AFP) in: 1)Human seru, as an aid in management of patients with non-seminomatous testicular cancer. 2) Maternal serum and amniotic fluid at 15 to 20 weeks gestation, to aid in the detection of fetal open neural tube defects (ONTD). The assay is intended for use in conjunction with other diagnostic tools such as ultrasound and amniography.